Semaglutide deep-dive Semaglutide is sold under three brand names, all manufactured by Novo Nordisk: Ozempic -- weekly injection, FDA-approved for type 2 diabetes (doses 0.25 mg, 0.5 mg, 1 mg, 2 mg) Wegovy -- weekly injection, FDA-approved for chronic weight management in 2021 (doses up to 2.4 mg) [3] Rybelsus -- daily oral tablet, approved for type 2 diabetes For weight loss specifically, Wegovy is the on-label choice
Lactating women need approximately 450 to 500 extra calories daily to maintain adequate milk production
Before you and your care team add GLP-1s, heres what experts say you should think about: You Might Finally Be Able to Get Help for Your Other Health Conditions Unfortunately, many people with bipolar disorder meet the on-label criteria for GLP-1s like obesity or type 2 diabetes yet are not being treated, says McIntyre
HSA and FSA are accepted with letters of medical necessity and itemized receipts